Andrew Mn Walker, Nicole T Watt, Nadira Y Yuldasheva, Sanjush Dalmia, Marcella Conning-Rowland, Chew W Cheng, Nele Warmke, Katherine Bridge, Oliver I Brown, Cheukyau Luk, Michael Drozd, Natalie J Haywood, Anna Skromna, Natasha Makava, Stephen B Wheatcroft, Mark T Kearney, Richard M Cubbon
OBJECTIVE: Reduced IGF-1 signalling is an evolutionarily conserved mediator of longevity, yet the magnitude of this effect is substantially larger in organisms retaining a common insulin and IGF-1 receptor. Whether this reflects the failure to simultaneously reduce IGF-1 and insulin signalling in mammalian model systems remains unexplored, as is the associated impact on markers of healthy ageing. We set out to address these uncertainties. METHODS: We compared the duration of healthy life (healthspan) in male mice with haploinsufficiency of the insulin receptor (IRKO), IGF-1 receptor (IGF-1RKO), or both (DKO), versus wildtype (WT) littermates...
August 30, 2024: Heliyon